Patient Blood Management for Neonates and Children Undergoing Cardiac Surgery: 2019 NATA Guidelines.
Antifibrinolytic Agents
/ therapeutic use
Blood Loss, Surgical
/ prevention & control
Blood Transfusion
/ methods
Cardiac Surgical Procedures
Heart Defects, Congenital
/ surgery
Hemorrhage
/ prevention & control
Humans
Infant, Newborn
Perioperative Care
/ methods
Postoperative Hemorrhage
/ prevention & control
Practice Guidelines as Topic
bleeding
congenital heart surgery
guidelines
patient blood management
pediatrics
transfusion
Journal
Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
19
02
2019
revised:
17
03
2019
accepted:
18
03
2019
pubmed:
12
5
2019
medline:
9
10
2020
entrez:
12
5
2019
Statut:
ppublish
Résumé
Pediatric cardiac surgery is associated with a substantial risk of bleeding, frequently requiring the administration of allogeneic blood products. Efforts to optimize preoperative hemoglobin, limit blood sampling, improve hemostasis, reduce bleeding, correct coagulopathy, and incorporate blood sparing techniques (including restrictive transfusion practices) are key elements of patient blood management (PBM) programs, and should be applied to the pediatric cardiac surgical population as across other disciplines. Many guidelines for implementation of PBM in adults undergoing cardiac surgery are available, but evidence regarding the implementation of PBM in children is limited to systematic reviews and specific guidelines for the pediatric cardiac population are missing. The objective of the task force from the Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis (NATA, www.nataonline.com) is to provide evidence-based recommendations regarding anemia management and blood transfusion practices in the perioperative care of neonates and children undergoing cardiac surgery, and to highlight potential areas where additional research is urgently required.
Identifiants
pubmed: 31076306
pii: S1053-0770(19)30296-4
doi: 10.1053/j.jvca.2019.03.036
pii:
doi:
Substances chimiques
Antifibrinolytic Agents
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3249-3263Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.